• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺多形性小叶原位癌(PLCIS)的筛检:核心活检诊断后并发浸润性恶性肿瘤的风险。

Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.

机构信息

Department of Pathology and Radiology, Bradford Royal Infirmary, Bradford, UK.

出版信息

Histopathology. 2010 Sep;57(3):472-8. doi: 10.1111/j.1365-2559.2010.03634.x. Epub 2010 Aug 19.

DOI:10.1111/j.1365-2559.2010.03634.x
PMID:20727019
Abstract

AIMS

Pleomorphic lobular carcinoma in situ (PLCIS) is an uncommon, recently recognized variant of lobular carcinoma in situ (LCIS). Its natural history, biological behaviour and clinical characteristics are uncertain. The aim was to review the radiological and pathological findings in a series of screen-detected PLCIS diagnosed on needle core biopsy with a view to determining the diagnostic features, immunohistological profile and risk of concurrent invasive malignancy.

METHODS AND RESULTS

Ten cases of core biopsy-diagnosed, screen-detected PLCIS were identified. Core biopsy findings were compared with pathological findings at subsequent surgery. Two cases were associated with possible microinvasion on the core. Two of 10 had invasive lobular carcinoma and one had microinvasive lobular carcinoma on subsequent surgical excision (positive predictive value for malignancy = 30%). There was associated conventional LCIS on either core or excision biopsy in all cases except one. All three cases of oestrogen receptor (ER)-negative PLCIS arose in the context of ER+ conventional LCIS.

CONCLUSIONS

PLCIS is a potentially more aggressive lesion than conventional LCIS and may present as mammographic calcification through a breast screening programme. Diagnosis may be problematic and immunohistochemical markers including ER may prove a useful diagnostic adjunct. There is a significant risk of concurrent invasive carcinoma following a core biopsy diagnosis.

摘要

目的

多形性小叶原位癌(PLCIS)是小叶原位癌(LCIS)中一种罕见的、最近才被认识的变异型。其自然史、生物学行为和临床特征尚不确定。本研究旨在回顾一系列经穿刺活检诊断为筛检性 PLCIS 的影像学和病理学表现,以确定其诊断特征、免疫组化特征和并发浸润性恶性肿瘤的风险。

方法和结果

确定了 10 例经核心活检诊断为筛检性 PLCIS 的病例。将核心活检结果与随后手术的病理结果进行比较。2 例核心活检存在可能的微浸润。在随后的手术切除中,有 2 例为浸润性小叶癌,1 例为微浸润性小叶癌(恶性肿瘤的阳性预测值=30%)。除 1 例外,所有病例在核心或切除活检中均有常规 LCIS 伴发。所有 3 例 ER 阴性 PLCIS 均发生在 ER 阳性常规 LCIS 背景下。

结论

PLCIS 是一种比常规 LCIS 更具侵袭性的病变,可能通过乳房筛查计划表现为乳腺钙化。诊断可能具有挑战性,包括 ER 在内的免疫组化标志物可能是一种有用的诊断辅助手段。在核心活检诊断后,存在并发浸润性癌的显著风险。

相似文献

1
Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.乳腺多形性小叶原位癌(PLCIS)的筛检:核心活检诊断后并发浸润性恶性肿瘤的风险。
Histopathology. 2010 Sep;57(3):472-8. doi: 10.1111/j.1365-2559.2010.03634.x. Epub 2010 Aug 19.
2
Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.乳腺粗针穿刺活检中的多形性小叶原位癌(PLCIS):临床意义及免疫表型
Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.
3
Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.多形性 LCIS 我们了解多少?一项英国多中心的多形性小叶原位癌研究。
Breast. 2018 Apr;38:120-124. doi: 10.1016/j.breast.2017.12.011. Epub 2018 Jan 5.
4
The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.乳腺小叶原位癌和不典型小叶增生的意义。
Ann Surg Oncol. 2012 Dec;19(13):4124-8. doi: 10.1245/s10434-012-2538-5. Epub 2012 Jul 31.
5
Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.在对粗针活检的小叶瘤变进行即刻和短期随访后发生的浸润性乳腺癌。
Am J Surg Pathol. 2003 Mar;27(3):325-33. doi: 10.1097/00000478-200303000-00005.
6
Challenges in the management of pleomorphic lobular carcinoma in situ of the breast.乳腺多形性小叶原位癌的管理难点。
Breast. 2013 Apr;22(2):194-196. doi: 10.1016/j.breast.2013.01.003. Epub 2013 Jan 26.
7
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.乳腺原位多形性小叶癌:单机构临床随访及集中病理检查经验
Breast Cancer Res Treat. 2017 Sep;165(2):411-420. doi: 10.1007/s10549-017-4334-1. Epub 2017 Jun 13.
8
Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.如果在粗针活检中发现小叶原位癌,则应进行切除活检。
Arch Pathol Lab Med. 2002 Jun;126(6):697-701. doi: 10.5858/2002-126-0697-EBSBPI.
9
Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.原位多形性小叶癌:放射学-病理学特征及临床处理
Ann Surg Oncol. 2015 Dec;22(13):4263-9. doi: 10.1245/s10434-015-4552-x. Epub 2015 Apr 17.
10
Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.经皮乳腺活检发现的小叶原位癌:手术活检结果
AJR Am J Roentgenol. 1999 Aug;173(2):291-9. doi: 10.2214/ajr.173.2.10430122.

引用本文的文献

1
Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.在核心针活检中诊断的乳腺原位癌的形态学亚型:临床病理特征和随访切除的发现。
Mod Pathol. 2021 Aug;34(8):1495-1506. doi: 10.1038/s41379-021-00796-9. Epub 2021 Apr 6.
2
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.美国病理学专家意见登记处:小叶原位癌的范围:诊断特征和临床意义。
Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15.
3
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
多形性和显著小叶原位癌的基因组分析揭示了高度复发的 ERBB2 和 ERRB3 改变。
Mod Pathol. 2020 Jul;33(7):1287-1297. doi: 10.1038/s41379-020-0459-6. Epub 2020 Jan 13.
4
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.多形性和华丽型小叶原位癌变异体的遗传分析:ERBB2/ERBB3 改变频繁,与经典小叶原位癌和浸润性小叶癌存在克隆关系。
Mod Pathol. 2020 Jun;33(6):1078-1091. doi: 10.1038/s41379-019-0449-8. Epub 2020 Jan 6.
5
How Do We Approach Benign Proliferative Lesions?我们应如何处理良性增殖性病变?
Curr Oncol Rep. 2018 Mar 23;20(4):34. doi: 10.1007/s11912-018-0682-1.
6
Lobular Carcinoma In Situ.小叶原位癌
Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8.
7
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.乳腺原位多形性小叶癌:单机构临床随访及集中病理检查经验
Breast Cancer Res Treat. 2017 Sep;165(2):411-420. doi: 10.1007/s10549-017-4334-1. Epub 2017 Jun 13.
8
Pleomorphic lobular carcinoma : Current evidence and a systemic review.多形性小叶癌:当前证据及系统评价
Oncol Lett. 2016 Dec;12(6):4863-4868. doi: 10.3892/ol.2016.5331. Epub 2016 Nov 1.
9
Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?乳腺原位多形性小叶癌:证据能否指导实践?
World J Clin Oncol. 2014 Aug 10;5(3):546-53. doi: 10.5306/wjco.v5.i3.546.
10
Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy.真空辅助乳腺活检中小叶原位癌的低估率
Eur Radiol. 2014 Jul;24(7):1651-8. doi: 10.1007/s00330-014-3132-y. Epub 2014 Apr 18.